1. The CHESME Health Economic Evaluations Database (CHESME HEED) project

   • Dimitrios Rovithis
   • Lycurgus Liaropoulos

   Editorial 19 March 2008 Pages: 99 - 101

2. Costing maternal health services in South Tanzania

   • Claudia von Both
   • Albrecht Jahn
   • Steffen Fleßa

   Original paper 24 April 2007 Pages: 103 - 115

   

3. Primary physicians’ response to changes in fees

   • Jostein Grytten
   • Fredrik Carlsen
   • Irene Skau

   Original paper 28 March 2007 Pages: 117 - 125

4. The search for good compliance: economic aspects of a conveyed combination pharmaco-therapy, exemplified by an osteoporosis therapy

   • Peter Oberender
   • Jürgen Zerth

   Original paper 20 April 2007 Pages: 127 - 136

   

5. Methodological issues in undertaking independent cost-effectiveness analysis for NICE: the case of therapies for ADHD

   • Susan C. Griffin
   • Helen L. A. Weatherly
   • Mike F. Drummond

   Original paper 03 May 2007 Pages: 137 - 145

6. The role of non-need factors in individual GP utilisation analysis and their implications for the pursuance of equity: a cross-country comparison

   • P. McGregor
   • P. McKee
   • C. O’Neill

   Original paper 11 April 2007 Pages: 147 - 156

7. Eligibility for free GP care, “need” and GP visiting in Ireland

   • A. Nolan
   • B. Nolan

   Original paper 24 April 2007 Pages: 157 - 163

8. Economic evaluation of the treatment of type 2 diabetes with insulin glargine based on the LAPTOP trial

   • Hans Uwe Janka
   • Barbara Högy

   Original paper 26 May 2007 Pages: 165 - 170

   

9. Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective

   • Jonathan Karnon
   • Thomas Delea
   • Vicki Barghout

   Original paper 30 June 2007 Pages: 171 - 183

   

10. The impact of generic substitution on price competition in Finland

    • Ville Aalto-Setälä

    Original paper 17 May 2007 Pages: 185 - 191

    

11. Spillover of cause-specific longevity interventions: an independent mortality risk model

    • Liqun Liu

    Original paper 05 June 2007 Pages: 193 - 201

12. Pharmacoeconomic evaluation of immunoglobulin treatment in patients with antibody deficiencies from the perspective of the German statutory health insurance

    • Barbara Högy
    • Heinz-Otto Keinecke
    • Michael Borte

    Erratum 18 August 2005 Pages: 203 - 203